PreveCeutical Medical Inc. (PRVCF) Research

Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering potential relief for ailments such as pain, inflammation, seizures, and various neurological disorders. Other key initiatives involve the BSV Peptide Program, aimed at halting cancer progression; a non-addictive analgesic for effective pain management; and a Dual Gene Therapy addressing type 2 diabetes and obesity. Furthermore, PreveCeutical is developing a diverse array of medicinal products based on cannabis.

Market snapshot

Symbol
PRVCF
Price
$0.01
Day change
-48.15%
Market cap
$15.0M
P/E ratio
-9.21x
52-week range
0.0037-0.0436
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Cell Source, Inc. (CLCS)
  • Gemina Laboratories Ltd. (GLABF)
  • Hemostemix Inc. (HMTXF)
  • EOM Pharmaceuticals Holdings, Inc. (IMUC)
  • Propanc Biopharma, Inc. (PPCB)
  • Quest PharmaTech Inc. (QPTFF)
  • Sirona Biochem Corp. (SRBCF)
  • Synairgen plc (SYGGF)

Open PreveCeutical Medical Inc. (PRVCF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.